CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 

PPBT's Net Income Growth by Quarter and Year

Purple Biotech Ltd 's Net Income results by quarter and year




PPBT Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 21.76 18.47 28.07 5.89
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   21.76 18.47 28.07 5.89



PPBT Net Income fourth quarter 2022 Y/Y Growth Comment
Purple Biotech Ltd reported Net Income increase of 17.81% year on year in the fourth quarter 2022, to $ 21.76 millions, this is lower than Purple Biotech Ltd 's recent average Net Income rise of 91.46%.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Net Income growth. While Purple Biotech Ltd ' s Net Income growth of 17.81% ranks overall at the positon no. 974 in the fourth quarter 2022.


PPBT Net Income ( Y/Y Growth %) 2022
 2021 2020 2019
IV Quarter December 17.81 % -34.2 % 376.57 % 5.75 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   17.81 % -34.2 % 376.57 % 5.75 %

Financial Statements
Purple Biotech Ltd 's fourth quarter 2022 Net Income $ 21.76 millions PPBT's Income Statement
Purple Biotech Ltd 's fourth quarter 2021 Net Income $ 18.47 millions Quarterly PPBT's Income Statement
New: More PPBT's historic Net Income Growth >>


PPBT Net Income (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   17.81 % -34.2 % 376.57 % 5.75 %


Compare PPBT Profitability >> Back to PPBT Growth rate Comparisons >>


Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #17
Healthcare Sector #60
Overall #974

Net Income Y/Y Growth Statistics
High Average Low
376.4 % 91.46 % -34.22 %
(Dec 31 2020)   (Dec 31 2021)
Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #17
Healthcare Sector #60
Overall #974
Net Income Y/Y Growth Statistics
High Average Low
376.4 % 91.46 % -34.22 %
(Dec 31 2020)   (Dec 31 2021)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Purple Biotech Ltd 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Net Income Comment


Purple Biotech Ltd 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
(Dec 31 2021)
Cumulative Net Income 12 Months Ending $ 21.76 $ 0.00 $ 0.00 $ 0.00 $ 18.47
Y / Y Net Income Growth (TTM) 17.83 % - - - -34.22 %
Year on Year Net Income Growth Overall Ranking # 1119 # 0 # 0 # 0 # 102
Seqeuential Net Income Change (TTM) 17.83 % - - - -34.22 %
Seq. Net Income Growth (TTM) Overall Ranking # 1091 # 0 # 0 # 0 # 102

New: More PPBT's historic Net Income Growth >>



Cumulative Net Income growth Comment
Although Purple Biotech Ltd 's Annual Net Income growth year on year were below company's average 91.46% , Net Income announced in the Dec 31 2022 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 17.83% year on year, from % in 0.

In the Healthcare sector 66 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 1119.

Net Income TTM Q/Q Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 67
Overall # 1119

Net Income TTM Y/Y Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 64
S&P 500 # 1091
Cumulative Net Income growth Comment
Although Purple Biotech Ltd 's Annual Net Income growth year on year were below company's average 91.46% , Net Income announced in the Dec 31 2022 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 17.83% year on year, from % in 0.

In the Healthcare sector 66 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 1119.

Net Income TTM Q/Q Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 67
Overall # 1119

Net Income TTM Y/Y Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 64
S&P 500 # 1091




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PPBT's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PPBT's Competitors
Net Income Growth for Purple Biotech Ltd 's Suppliers
Net Income Growth for PPBT's Customers

You may also want to know
PPBT's Annual Growth Rates PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Comparisons



Companies with similar Net Income growth for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2022
Vericel Corporation30.58%$ 30.584 millions
Bruker Corporation29.34%$ 29.342 millions
Cadre Holdings inc 24.37%$ 24.369 millions
Alpha Tau Medical ltd 23.80%$ 23.802 millions
Ensign Group Inc23.61%$ 23.607 millions
Neurocrine Biosciences Inc 22.25%$ 22.253 millions
Staar Surgical Company18.92%$ 18.915 millions
Edwards Lifesciences Corporation18.82%$ 18.819 millions
Purple Biotech Ltd 17.83%$ 17.825 millions
United Therapeutics Corporation17.74%$ 17.736 millions
Integra Lifesciences Holdings Corp16.66%$ 16.662 millions
Electromed Inc 16.59%$ 16.587 millions
Mettler Toledo International Inc15.14%$ 15.144 millions
Option Care Health Inc 14.98%$ 14.979 millions
Addus Homecare Corporation13.05%$ 13.049 millions
Eli Lilly And Company12.26%$ 12.259 millions
Resmed Inc 11.48%$ 11.481 millions
Zoetis Inc 11.38%$ 11.380 millions
Check cap Ltd 11.08%$ 11.080 millions
Utah Medical Products Inc10.26%$ 10.261 millions
Exicure Inc 9.92%$ 9.919 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com